Gm-negative ehv-mutants

Details for Australian Patent Application No. 2001248313 (hide)

Owner Boehringer Ingelheim Vetmedica GmbH

Inventors Osterrieder, Nikolaus; Seyboldt, Christian; Elbers, Knut

Agent Davies Collison Cave

Pub. Number AU-B-2001248313

PCT Pub. Number WO01/60403

Priority 00103241 17.02.00 EP

Filing date 15 February 2001

Wipo publication date 27 August 2001

Acceptance publication date 2 March 2006

International Classifications

A61K 39/27 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/03 (2006.01) Peptides having more than 20 amino acids

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

C12N 15/38 (2006.01) Mutation or genetic engineering

Event Publications

2 March 2006 Application Accepted

  Published as AU-B-2001248313

29 June 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001248314-Use of Oprl lipoprotein from pseudomonas as a Th1 inducing natural adjuvant for heterologous antigens

2001248311